From proteins to virus particles: the structure and function of virions

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:12 publications

Grant number: MC_UU_00034/1

Grant search

Key facts

  • Disease

    COVID-19, Unspecified
  • Start & end year

    2023
    2028
  • Known Financial Commitments (USD)

    $6,848,791.04
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    David Bhella
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Glasgow
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Structural biology aims to understand how the shapes of the molecules of life, such as viral proteins, direct their functions. This is achieved by experimental determination of the 3D shape of biological molecules at the level of their individual atoms. Atomic structures can be combined with mathematical models of how molecules might move (molecular dynamics) and how they might evolve to evade host defences. Understanding the structure, dynamics and evolution of viral proteins can give researchers new ways to think about viral infections which can be tested in the laboratory. In this programme we will bring together expertise in structural biology (Bhella, Carter), molecular dynamics (Grove), mathematical modelling (Illingworth) and molecular and compositional biology (Hutchinson) to study the structure and function of virus particles (virions) of influenza viruses, coronaviruses and respiratory syncytial virus.

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD.

Pasteurisation temperatures effectively inactivate influenza A viruses in milk.

SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.

A ~40-kb flavi-like virus does not encode a known error-correcting mechanism.

Bunyamwera Virus Infection of <i>Wolbachia</i>-Carrying <i>Aedes aegypti</i> Mosquitoes Reduces <i>Wolbachia</i> Density.

Cryptic proteins translated from deletion-containing viral genomes dramatically expand the influenza virus proteome.

Multiplexed Biosensing of Proteins and Virions with Disposable Plasmonic Assays.

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature.

Respiratory viruses: New frontiers-a Keystone Symposia report.